Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

CLRB

Cellectar Biosciences, Inc.

CIK 0001279704 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$2.59
↑ 0.00 (0.00%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$20.70M
P/E Ratio
-0.93
EPS
-8.35
Dividend Yield
Not covered
52W Position
9%
Beta
1.73

Valuation multiples

Fwd P/E
Not covered
PEG
0.00
P/B
0.69
P/S
Not covered
EV/Revenue
Not covered
ROE
-74.7%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 9%
$2.20$6.52

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$21.79M
Total Assets
$14.98M
Free Cash Flow
-$23.12M

Recent news